Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons
about
Urinary Markers of Tubular Injury in HIV-Infected PatientsEpidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patientsChanges in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine.Recurrent HIV-associated immune complex glomerulonephritis with lupus-like features after kidney transplantationProteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individualsA chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans.The New Epidemiology of HIV-Related Kidney Disease.Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patients.Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adultsExercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity.Recent developments in HIV-related kidney disease.Albuminuria is associated with elevated acute phase reactants and proinflammatory markers in HIV-infected patients receiving suppressive combination antiretroviral therapy.Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.Reduced kidney function and preclinical atherosclerosis in HIV-infected individuals: the study of fat redistribution and metabolic change in HIV infection (FRAM)Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy.Chronic kidney disease and estimates of kidney function in HIV infection: a cross-sectional study in the multicenter AIDS cohort study.Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected personsNeither proteinuria nor albuminuria is associated with endothelial dysfunction in HIV-infected patients without diabetes or hypertension.Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy.APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease.Albuminuria Is Associated with Traditional Cardiovascular Risk Factors and Viral Load in HIV-Infected Patients in Rural South Africa.Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors.Preventing Heart Failure in Inflammatory and Immune DisordersElevation of Non-Classical (CD14+/lowCD16++) Monocytes Is Associated with Increased Albuminuria and Urine TGF-β1 in HIV-Infected Individuals on Stable Antiretroviral Therapy.Markers of renal disease and function are associated with systemic inflammation in HIV infection.Prevalence of anemia in renal insufficiency among HIV infected patients initiating ART at a hospital in Northeast Ethiopia.Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients.Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.Urinary markers of kidney injury and kidney function decline in HIV-infected womenThe Incidence and Clinical Characteristics of Acute Serum Creatinine Elevation more than 1.5 mg/dL among the Patients Treated with Tenofovir/Emtricitabine-containing HAART RegimensSwitching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 StudyTenofovir exposure alters associations of serum bicarbonate with chronic kidney disease risk in HIV-infected veteransRacial Disparities in Creatinine-based Kidney Function Estimates Among HIV-infected Adults.Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients.Association of tenofovir exposure with kidney disease risk in HIV infection.Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users.Host APOL1 genotype is independently associated with proteinuria in HIV infectionDyslipidemia and cardiovascular risk in human immunodeficiency virus infection.The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: Meta-analysis.
P2860
Q26738912-17D5C7DE-4F9E-4ACD-8C24-9997BD61B1AEQ27009523-0C92E240-DF65-4B3C-9FDB-39A9AC76B92FQ30842348-7B16E7B7-5CD1-40EC-903A-1F64C6967E98Q34000738-C329A7CF-8183-49D0-B091-256F353E5330Q34048920-51BE8367-D291-42DB-BD63-3E185110FFD9Q34301401-33F37D57-3241-4204-B392-2D7116EEBAB2Q34307868-2FC9B64E-FAF5-4814-8F5A-56870BFB5055Q34375843-14FB3D0A-8E46-48A3-A6B2-ED8E65385EC6Q34387456-85DDF071-ED11-4BCE-950D-0B8B613F84C6Q34501780-ABA92B07-7366-4616-9275-6AFDA9FA7ED4Q34572458-55623352-14BE-44F2-841E-0F52FB7E9CD1Q34606582-39F927F4-267E-4895-9184-A7DF73451EECQ34736194-9654B6D8-2E69-46B4-AE14-923F8A056F69Q34736818-4E072E0B-E801-4852-81C9-9063700A86D8Q35000346-62FBF76D-0BC5-402E-94C6-753EC5335875Q35059316-BFB76394-3802-4A61-89A4-9DF14A5E7044Q35175515-5BF900D5-B20C-463A-A366-D183D5D7212EQ35189962-B1C37148-3540-4524-9BC4-2E49610B60F5Q35532872-5BB2FF60-9E52-4D1A-AF87-9EF9F6B58A3BQ35560802-DACB7396-416E-4BF1-BBB1-4F822962F7B6Q35715828-7EF556AF-2513-4BEC-A3F1-6BA708361063Q35756256-E4BE455F-C501-4C20-BA38-1EA824630102Q35883947-E93A4C89-BFEC-4274-B28E-5B31834CCBD3Q35994802-0F20B67B-FCDB-48EB-9823-DCD600F19C8DQ35994939-1E8EE4AE-C37B-4F5E-B9B9-6D4B25DACEBBQ36206108-919E8765-FF9A-44ED-9A44-D2D0FB44CD0CQ36258268-4F54941B-70F0-4278-8FAF-C20DBE423AAFQ36311127-C94DF0EB-D954-4A8F-A456-B7D2639CAF76Q36334834-1320E5EF-070E-4B48-8019-490945D32D50Q36431302-2BF5A2B1-3CF2-4F1C-AE5C-9C48F58EACA5Q36472367-936145BD-1106-4519-890D-747D49522B54Q36721012-20A2450E-631D-40F9-BB10-88B3DE1E3EABQ36746411-36D65187-4A89-4782-9B12-F648B699D5ACQ36813322-3BB1E3A8-5111-4260-9BAC-7FF513B83046Q36852879-3134CFBC-AA40-4CFE-AB1C-D5A26172F7B7Q37077982-54E20EA1-34BA-4BCC-9782-A9C181958034Q37155210-FE74FD48-53B9-405E-B3DF-39D1595B9DF0Q37211299-B86311D3-9F8D-43C8-AF6F-8C2E4D0C0FDDQ37319195-4C096C8B-E4A0-48DF-963A-D2DDD148813DQ37354871-C5B9251F-F89E-4102-B9C7-C5794F52126A
P2860
Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Association between kidney fun ...... events in HIV-infected persons
@ast
Association between kidney fun ...... events in HIV-infected persons
@en
type
label
Association between kidney fun ...... events in HIV-infected persons
@ast
Association between kidney fun ...... events in HIV-infected persons
@en
prefLabel
Association between kidney fun ...... events in HIV-infected persons
@ast
Association between kidney fun ...... events in HIV-infected persons
@en
P2093
P2860
P1433
P1476
Association between kidney fun ...... events in HIV-infected persons
@en
P2093
Andy I Choi
Carl Grunfeld
Paul A Volberding
Yongmei Li
P2860
P304
P356
10.1161/CIRCULATIONAHA.109.898585
P407
P577
2010-01-25T00:00:00Z